04/03/2011

MeTA Country Guidance Note

This note provides advice and guidance to existing and prospective MeTA pilot countries – and specifically their national Secretariats and multi-stakeholder groups or Councils – as they take steps towards establishing the practice of routine disclosure of key medicines data.